GPP-TSAIII nanocomposite hydrogel-based photothermal ablation facilitates melanoma therapy
BACKGROUND: Photothermal therapy (PTT) is a promising cancer treatment, but its application is limited by low photoconversion efficiency. In this study, we aimed to develop a novel graphene oxide (GO)-based nanocomposite hydrogel to improve the bioavailability of timosaponin AIII (TSAIII) while maximizing PTT efficacy and enhancing the antitumor effect.
METHODS: GO was modified via physical cross-linking with polyvinyl alcohol. The pore structure of the gel was adjusted by repeated freeze-thawing and the addition of polyethylene glycol 2000 to obtain a nanocomposite hydrogel (GPP). The GPP loaded with TSAIII constituted a GPP-TSAIII drug delivery system, and its efficacy was evaluated by in vitro cytotoxicity, apoptosis, migration, and uptake analyses, and in vivo antitumor studies.
RESULTS: The encapsulation rate of GPP-TSAIII was 66.36 ± 3.97%, with slower in vitro release and higher tumor cell uptake (6.4-fold) compared to TSAIII. GPP-TSAIII in combination with PTT showed better bioavailability and antitumor effects in vivo than did TSAIII, with a 1.9-fold higher tumor suppression rate than the TSAIII group.
CONCLUSIONS: GPP is a potential vehicle for delivery of TSAIII-like poor water-soluble anticancer drugs. The innovative PTT co-delivery system may serve as a safe and effective melanoma treatment platform for further anticancer translational purposes.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:20 |
---|---|
Enthalten in: |
Expert opinion on drug delivery - 20(2023), 9 vom: 19. Juli, Seite 1277-1295 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Huang, Xing [VerfasserIn] |
---|
Links: |
---|
Themen: |
Antineoplastic Agents |
---|
Anmerkungen: |
Date Completed 02.11.2023 Date Revised 02.11.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1080/17425247.2023.2200997 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM355438577 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM355438577 | ||
003 | DE-627 | ||
005 | 20231226064339.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1080/17425247.2023.2200997 |2 doi | |
028 | 5 | 2 | |a pubmed24n1184.xml |
035 | |a (DE-627)NLM355438577 | ||
035 | |a (NLM)37039332 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Huang, Xing |e verfasserin |4 aut | |
245 | 1 | 0 | |a GPP-TSAIII nanocomposite hydrogel-based photothermal ablation facilitates melanoma therapy |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 02.11.2023 | ||
500 | |a Date Revised 02.11.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a BACKGROUND: Photothermal therapy (PTT) is a promising cancer treatment, but its application is limited by low photoconversion efficiency. In this study, we aimed to develop a novel graphene oxide (GO)-based nanocomposite hydrogel to improve the bioavailability of timosaponin AIII (TSAIII) while maximizing PTT efficacy and enhancing the antitumor effect | ||
520 | |a METHODS: GO was modified via physical cross-linking with polyvinyl alcohol. The pore structure of the gel was adjusted by repeated freeze-thawing and the addition of polyethylene glycol 2000 to obtain a nanocomposite hydrogel (GPP). The GPP loaded with TSAIII constituted a GPP-TSAIII drug delivery system, and its efficacy was evaluated by in vitro cytotoxicity, apoptosis, migration, and uptake analyses, and in vivo antitumor studies | ||
520 | |a RESULTS: The encapsulation rate of GPP-TSAIII was 66.36 ± 3.97%, with slower in vitro release and higher tumor cell uptake (6.4-fold) compared to TSAIII. GPP-TSAIII in combination with PTT showed better bioavailability and antitumor effects in vivo than did TSAIII, with a 1.9-fold higher tumor suppression rate than the TSAIII group | ||
520 | |a CONCLUSIONS: GPP is a potential vehicle for delivery of TSAIII-like poor water-soluble anticancer drugs. The innovative PTT co-delivery system may serve as a safe and effective melanoma treatment platform for further anticancer translational purposes | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Photothermal therapy | |
650 | 4 | |a Timosaponin AIII | |
650 | 4 | |a graphene oxide | |
650 | 4 | |a melanoma | |
650 | 4 | |a mitochondria | |
650 | 4 | |a tumor therapy | |
650 | 7 | |a Nanogels |2 NLM | |
650 | 7 | |a Antineoplastic Agents |2 NLM | |
700 | 1 | |a He, Yihao |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Miao |e verfasserin |4 aut | |
700 | 1 | |a Lu, Zhenhui |e verfasserin |4 aut | |
700 | 1 | |a Zhang, Tong |e verfasserin |4 aut | |
700 | 1 | |a Wang, Bing |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Expert opinion on drug delivery |d 2004 |g 20(2023), 9 vom: 19. Juli, Seite 1277-1295 |w (DE-627)NLM159019028 |x 1744-7593 |7 nnns |
773 | 1 | 8 | |g volume:20 |g year:2023 |g number:9 |g day:19 |g month:07 |g pages:1277-1295 |
856 | 4 | 0 | |u http://dx.doi.org/10.1080/17425247.2023.2200997 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 20 |j 2023 |e 9 |b 19 |c 07 |h 1277-1295 |